Yuyu Pharma, Inc. (KRX:000220)

Market Cap	71.20B
Revenue (ttm)	134.79B
Net Income (ttm)	8.56B
Shares Out	16.18M
EPS (ttm)	528.75
PE Ratio	8.32
Forward PE	n/a
Dividend	100.00 (2.26%)
Ex-Dividend Date	Dec 27, 2024

Volume	41,639
Average Volume	38,756
Open	4,420.00
Previous Close	4,420.00
Day's Range	4,325.00 - 4,440.00
52-Week Range	3,900.00 - 5,810.00
Beta	0.47
RSI	34.12
Earnings Date	Feb 28, 2025

About Yuyu Pharma

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 253
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000220

Financial Performance

In 2023, Yuyu Pharma's revenue was 137.21 billion, a decrease of -1.20% compared to the previous year's 138.88 billion. Losses were -7.21 billion, 14.9% more than in 2022.